Clinical Trials Browser

OTHER × Observational × Locally Advanced Pancreatic Adenocarcinoma × Clear all

NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Active not recruiting

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma